Clearside Biomedical Inc. (CLSD)

Name: Clearside Biomedical Inc. (CLSD) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Clearside Biomedical Inc. (CLSD)

Stock Card

$0.71

$0.30 (73.17%)

As on 26-Dec-2025 09:30EDT

Market cap

$2 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

P/B Ratio

3.9

Div. Yield

0 %

Clearside Biomedical (CLSD) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.70 High: 0.81

52 Week Range

Low: 0.37 High: 17.10

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-13.1 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-2.8
Debt to Equity

0
Book Value

$--
EPS

$-5.1
Face value

--
Shares outstanding

5,233,981

10 Years Aggregate

CFO

$-258.44 Mln

EBITDA

$-295.83 Mln

Net Profit

$-310.27 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Clearside Biomedical (CLSD)	-95.0	18.3	-81.0	-94.9	-65.4	-52.6	--
BSE Sensex^*	-9.1	-1.2	2.9	-3.6	5.7	6.2	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 26-Dec-2025 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2024	2023	2022	2021	2020	2019	2018
Clearside Biomedical (CLSD)	-18.7	4.5	-59.3	0.4	-5.5	171.0	-84.6
S&P Small-Cap 600	7.0	13.9	-17.4	25.3	9.6	20.9	-9.7
BSE Sensex	8.1	18.7	4.4	22.0	15.8	14.4	5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Clearside Biomedical (CLSD)

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for... the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. On November 23, 2025, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Read more

President, CEO & Director

Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
President, CEO & Director

Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Headquarters

Alpharetta, GA
Website

https://clearsidebio.com

FAQs for Clearside Biomedical (CLSD)

What is the current share price of Clearside Biomedical Inc (CLSD) Today?

The share price of Clearside Biomedical Inc (CLSD) is $0.71 (NASDAQ) as of 26-Dec-2025 09:30 EDT. Clearside Biomedical Inc (CLSD) has given a return of -65.37% in the last 3 years.

What is the current PB & PE ratio of Clearside Biomedical Inc (CLSD)?

Since, TTM earnings of Clearside Biomedical Inc (CLSD) is negative, P/E ratio is not available.
The P/B ratio of Clearside Biomedical Inc (CLSD) is 3.93 times as on 26-Dec-2025, a 24 discount to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2024	-0.14	-0.12
2023	-0.15	-0.31
2022	-0.14	0.43
2021	29.83	0.30
2020	-0.50	1.02

What is the 52 Week High and Low of Clearside Biomedical Inc (CLSD)?

The 52-week high and low of Clearside Biomedical Inc (CLSD) are Rs 17.10 and Rs 0.37 as of 31-Aug-2026.

What is the market cap of Clearside Biomedical Inc (CLSD)?

Clearside Biomedical Inc (CLSD) has a market capitalisation of $ 2 Mln as on 26-Dec-2025. As per SEBI classification, it is a Small Cap company.

Should I invest in Clearside Biomedical Inc (CLSD)?

Before investing in Clearside Biomedical Inc (CLSD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.